The Effect of Joint Range of Motion and Benson Relaxation Exercises on Dialysis Adequacy, Treatme… (NCT07410416) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The Effect of Joint Range of Motion and Benson Relaxation Exercises on Dialysis Adequacy, Treatment Adherence, and Quality of Life in Hemodialysis Patients
72 participantsStarted 2026-03-01
Plain-language summary
The aim of this study is to determine the effects of range of motion and Benson relaxation exercises applied to patients undergoing hemodialysis treatment on dialysis adequacy, treatment adherence, and quality of life.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Being 18 years of age or older
* Receiving HD treatment for at least 1 year
* Receiving HD treatment 3 days a week for 4 hours
* Being able to speak Turkish
* Volunteering to participate in the study
Exclusion Criteria:
* Patients with chronic diseases affecting breathing (advanced COPD, cancer)
* Patients with hearing or speech problems
* Patients with a diagnosed psychiatric condition
* Patients with conditions that impede movement, such as burns, open wounds, edema, thrombophlebitis, limited mobility, fistulas, or previous surgical operations in the extremities
Exclusion Criteria from the Study:
* Patients whose HD center changed during the study
* Patients who did not wish to continue with the study
* Patients who received a diagnosis of neurological or psychiatric illness during the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
SEVEN-POINT SUBJECTIVE GLOBAL ASSESSMENT (SGD-7P)
Timeframe: From enrollment to the end of treatment at 8 weeks
2
END-STAGE RENAL FAILURE - COMPLIANCE SCALE
Timeframe: From enrollment to the end of treatment at 8 weeks
3
Kidney Disease Patients Quality of Life Scale (KDQOL-36)
Timeframe: From enrollment to the end of treatment at 8 weeks